Translation of foreign currency net debt into US Dollars had the effect of increasing net debt by $13m in the three-year period ended 31 December 2006.
Closing net cash includes $2m of net currency swap liabilities 2005 net currency swap liabilities of $19m and 2004 net currency swap assets of $61m.
Net Cash Inflow from Operating Activities Cash generated from operations in 2006 of $506m is after paying out $33m of macrotextured claim settlements unreimbursed by insurers, $4m of bid related costs, $21m of restructuring and rationalisation costs and $26m of  of currentservice cost.
In 2005 cash generated from operations of $372m was after paying $47m for macrotextured claim settlements unreimbursed by insurers, $7m of restructuring and rationalisation costs and $86m of special pension contributions.
In 2004 cash generated from operations of $415m was after paying $32m of macrotextured claim settlements unreimbursed by insurersand $4m of .
Capital Expenditure The Groups ongoingcapital expenditure and workingcapital requirements have been financedthroughcash flow generated by business operations and, where necessary, through short-term committed and uncommitted bank facilities.
In recent years capital expenditure on tangible and intangible fixed assets has represented approximately 8% of  and is expected to be the same in2007.
In 2006 capital expenditure of $231m $222m net of disposals of property, plant and equipment was incurred.
The principal areas of investment were the placement of reconstruction and trauma instruments with customers, patents and licenses, plant and equipment and .
At 31 December 2006, $2m of capital expenditure had been contracted but not provided for whichwill be funded from cash inflows.
44 Acquisitions and Disposals In the three-year period ended 31 December 2006, $263m including the issuance of $91m of Loan Notes in 2004 was spent on acquisitions, funded from net debt and cash inflows.
Acquisitions comprised OBI $73m, MMT $129m, Acticoat $15m, Versajet $12m, Collagenase $10m and other $24m.
$537m net of costs was received from the disposal of BSN Medical in2006.
Liquidity The Groups policy is to ensure that it has sufficient funding and facilities in place to meet foreseeable borrowing requirements.
New borrowing facilities of $2.5bn are currently being negotiated to replace $0.6bn of existing facilities in order to fund the acquisition of Plus $0.9bn and share buybacks $1.5bn.
A bridging facility of $550m has been arranged for a period of six monthspendingthe agreement of these new facilities.
At 31 December 2006, the Group held $346m in cash and balances at bank and had committed and uncommitted bank facilities of $610m and $446m respectively.
Undrawn bank facilities amounted to $955m, of which $610m were committed.
Of the undrawn committed facilities, $10m expires within one year and $600m after two but within five years.
Of the drawn facilities, all expire within one year.
In addition Smith & Nephew has $17m of loan notes payable within one year and finance lease commitments of $16m of which $10m extends beyond five years.
Smith & Nephew intends to repay the amounts due within one year by using available cash and drawingdownonthe .
The principal variations in the Groups borrowing requirements result from the timing of dividend payments, acquisitions and disposals of businesses, the share buyback, timing of capital expenditure and working capital fluctuations.
In 2006 the settlement of macrotextured patient claims was a factor which will continue in 2007.
In February 2006 the Group received $537m net from the sale of the BSN Medical joint venture which was used to repay borrowingfacilities.
Smith & Nephew believes that its capital expenditure needs and its working capital funding for 2007, as well as its other knownorexpected , canbe met from its existing resources and facilities.
Existing provisions and planned future contributions are considered adequate to cover the current under funded positioninthe Groups defined benefit plans.
Further information regarding borrowings at 31 December 2006 is set out in Note 19 of the Notes to the Group Accounts.
The Group believes that the borrowing facilities do not contain restrictions that are expected to impact  policyfor the foreseeable future.
Payment Policies It is the Groups policy to ensure that suppliers are paid within agreed terms.
At the year-end, the parent Companyhad notrade creditors.
